- Home
- VALN vs HBNC Comparison
VALN vs HBNC Comparison
Compare VALN & HBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALN
- HBNC
- Stock Information
- Founded
- VALN 2012
- HBNC 1873
- Country
- VALN France
- HBNC United States
- Employees
- VALN N/A
- HBNC N/A
- Industry
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- HBNC Major Banks
- Sector
- VALN Health Care
- HBNC Finance
- Exchange
- VALN Nasdaq
- HBNC Nasdaq
- Market Cap
- VALN 669.2M
- HBNC 708.6M
- IPO Year
- VALN 2021
- HBNC N/A
- Fundamental
- Price
- VALN $9.11
- HBNC $15.22
- Analyst Decision
- VALN Strong Buy
- HBNC Hold
- Analyst Count
- VALN 3
- HBNC 2
- Target Price
- VALN $15.33
- HBNC $18.00
- AVG Volume (30 Days)
- VALN 65.5K
- HBNC 210.6K
- Earning Date
- VALN 08-12-2025
- HBNC 07-23-2025
- Dividend Yield
- VALN N/A
- HBNC 4.26%
- EPS Growth
- VALN N/A
- HBNC 170.68
- EPS
- VALN N/A
- HBNC 1.17
- Revenue
- VALN $201,099,222.00
- HBNC $211,581,000.00
- Revenue This Year
- VALN $18.61
- HBNC $47.48
- Revenue Next Year
- VALN $25.07
- HBNC $4.01
- P/E Ratio
- VALN N/A
- HBNC $12.85
- Revenue Growth
- VALN 21.64
- HBNC 17.55
- 52 Week Low
- VALN $3.62
- HBNC $12.70
- 52 Week High
- VALN $9.10
- HBNC $19.18
- Technical
- Relative Strength Index (RSI)
- VALN 80.93
- HBNC 45.06
- Support Level
- VALN $7.15
- HBNC $14.98
- Resistance Level
- VALN $7.82
- HBNC $15.45
- Average True Range (ATR)
- VALN 0.40
- HBNC 0.41
- MACD
- VALN 0.14
- HBNC -0.09
- Stochastic Oscillator
- VALN 99.37
- HBNC 27.42
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
About HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.